OPEN END TURBO OPTIONSSCHEIN LONG - QUEST DIAGNOSTICS | Real-time BOERSE MUENCHEN 09:25:11 26/06/2024 BST | ||
| 1.53 EUR | 0.00% |
|
| Current month | -13.56% | ||
| 1 month | -15.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 1.53 | 0.00% |
| 25/06/24 | 1.53 | -7.27% |
| 24/06/24 | 1.65 | +3.77% |
| 21/06/24 | 1.59 | +8.16% |
| 20/06/24 | 1.47 | +1.38% |
Real-time BOERSE MUENCHEN
Last update June 26, 2024 at 09:25 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ4F4J |
| ISIN | DE000GQ4F4J1 |
| Date issued | 05/09/2023 |
| Strike | 122.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.49 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.28 € |
|---|---|
| Lowest since issue | 0.504 € |
| Spread | 0.05 € |
| Spread % | 3.21% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.3
USD
Average target price
147
USD
Spread / Average Target
+6.29%
- Stock Market
- Certificates
- Certificat
